|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|
| Cash flows from operating activities: | |||
| Net loss | |||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||
| Stock-based compensation expense | |||
| Depreciation | |||
| Amortization/accretion of investments | |||
| Loss on disposal of property and equipment | |||
| Changes in operating assets and liabilities: | |||
| Related party receivables, net | |||
| Prepaid expenses and other assets | |||
| Operating lease right-of-use assets and liabilities, net | |||
| Accounts payable and accrued expenses | |||
| Net cash used in operating activities | |||
| Cash flows from investing activities: | |||
| Purchases of short-term and long-term investments | |||
| Sales and maturities of short-term and long-term investments | |||
| Purchases of property and equipment | |||
| Net cash provided by (used in) investing activities | |||
| Cash flows from financing activities: | |||
| Proceeds from issuance of common stock in initial public offering, net of issuance costs | |||
| Issuance costs for Series B convertible preferred stock | |||
| Proceeds from issuance of Series C convertible preferred stock, net of issuance costs | |||
| Proceeds (payments) upon stock option exercises, net of shares acquired upon forfeiture | |||
| Acquisition of redeemable convertible noncontrolling interests | |||
| Proceeds from issuance of common stock under equity incentive plans | |||
| Proceeds from issuance of common stock under employee stock purchase plan | |||
| Payment of deferred offering costs | |||
| Net cash (used in) provided by financing activities | |||
| Effect of exchange rate changes on cash and cash equivalents | |||
| Net increase (decrease) in cash, cash equivalents and restricted cash | |||
| Cash, cash equivalents and restricted cash at the beginning of the period | |||
| Cash, cash equivalents and restricted cash at the end of the period | |||
| Supplemental non-cash investing and financing activity: | |||
| Acquisition of redeemable convertible noncontrolling interests | |||
| Capitalized value of tenant improvement allowance | |||
| Operating lease liabilities arising from obtaining right-of-use assets | |||
| Write-off of deferred offering costs | |||
| Deferred offering costs included in accounts payable and accrued expenses |
Loading...
